Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05191485 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Shared Decision Making in Patients With Lung Cancer

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2025 to Dec 31, 2026
    • Study completion date: Dec 2026 to Dec 2027
    v8
  2. Collaborators reorderedv7
  3. Primary completion date: Dec 31, 2023 to Dec 31, 2025
    • Start date: Feb 22, 2022 to Feb 22, 2023
    • Study completion date: Dec 2025 to Dec 2026
    v6
  4. Primary completion date: Dec 2022 to Dec 31, 2023
    • Study completion date: Jun 2023 to Dec 2025
    v5
  5. Primary completion date: Aug 2022 to Dec 2022
    • Study completion date: Dec 2022 to Jun 2023
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 2022 to Feb 22, 2022
    • Site details revised
    • Collaborators: 5 to 4
    v3
  2. Start date: Jan 2022 to Feb 2022
    • Eligibility criteria shortened, about 93 words
    • Collaborators: 1 to 5
    • Study description expanded, about 1 word
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to develop a Decision Aid for Lung Cancer Molecular Testing (DA\_LCMT) and to facilitate shared-decision making in patients who were diagnosed with lung adenocarcinoma by intraoperative frozen pathology about whether to conduct the molecular testing.
Trial Details
NCT Number NCT05191485
Lead Sponsor Sichuan Cancer Hospital and Research Institute
Collaborators: Jiangyou People's Hospital, Wu Jieping Medical Foundation, Chongqing Medical University, The Third People's Hospital of Chengdu
Conditions
(from sponsor)		 Surgery, Lung Adenocarcinoma
Related terms Adenocarcinoma of Lung
Enrollment 190 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov